You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Higher Risk Myelodysplastic Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)

Available
  • Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Magrolimab
  • (no location specified)
Jan 18, 2023

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • (no location specified)
Jul 29, 2022

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in United

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Los Angeles, California
  • +4 more
Oct 5, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome
  • ASP7517
  • Duarte, California
  • +15 more
Jan 19, 2023

MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

Recruiting
  • Myelodysplastic Syndromes
  • Unrelated Umbilical Cord Blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma Trial (3D189)

Recruiting
  • Acute Leukemia
  • +3 more
  • 3D189
  • Guangzhou, Guangdong, China
  • +3 more
Jan 2, 2023

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Rochester, Minnesota
  • +1 more
Feb 15, 2023

Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

Not yet recruiting
  • Untreated Myelodysplastic Syndrome
  • Onureg + Venetoclax
  • Angers, France
  • +9 more
Mar 13, 2023

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

Myelodysplastic Syndrome Trial in Suzhou (AK117, Azacitidine)

Recruiting
  • Myelodysplastic Syndrome
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 21, 2021

High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

Active, not recruiting
  • High Risk Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

MDS Trial in Tampa, Saint Louis, Seattle (CPX-351, Research skin biopsy, Research blood draw)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
Apr 1, 2022

MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 2, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

MDS Trial in Tianjin (IBI188+azacitidine, Drug:Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tianjin, China
    Blood Diseases Hospital Chinese Academy Of Medical Science
Mar 9, 2021

Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

Recruiting
  • Haematological Malignancy
  • +4 more
  • Phoenix, Arizona
  • +14 more
Aug 22, 2022

AML, Adult Trial in Australia, China, United States (APG 2575 ramp up arm)

Recruiting
  • AML, Adult
  • APG 2575 ramp up arm
  • Baltimore, Maryland
  • +6 more
Aug 12, 2022

Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
Jan 23, 2023

MDS Trial (Pevonedistat, Azacitidine)

No longer available
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 8, 2021

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
Sep 23, 2021

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +23 more
Aug 1, 2022

MDS(MDS) Trial in China (Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA))

Not yet recruiting
  • Myelodysplastic Syndromes(MDS)
  • Lemzoparlimab+Azacitidine (AZA)
  • Azacitidine (AZA)
  • Bengbu, An Hui, China
  • +44 more
Jan 29, 2023

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023